The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer
出版年份 2014 全文链接
标题
The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer
作者
关键词
-
出版物
Applied Physiology Nutrition and Metabolism
Volume 39, Issue 6, Pages 693-698
出版商
Canadian Science Publishing
发表日期
2014-01-24
DOI
10.1139/apnm-2013-0403
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
- (2013) Carla M Prado et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Assessment of Nutritional Status in Cancer – The Relationship Between Body Composition and Pharmacokinetics
- (2013) Carla Prado et al. Anti-Cancer Agents in Medicinal Chemistry
- Body composition in chemotherapy
- (2013) Carla M.M. Prado CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarcopenic obesity: A Critical appraisal of the current evidence
- (2012) C.M.M. Prado et al. CLINICAL NUTRITION
- Reducing the toxicity of cancer therapy: recognizing needs, taking action
- (2012) Charles S. Cleeland et al. Nature Reviews Clinical Oncology
- Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
- (2010) Vickie E Baracos et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial
- (2010) A. Poveda et al. ANNALS OF ONCOLOGY
- Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
- (2010) S. Antoun et al. ANNALS OF ONCOLOGY
- An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity
- (2010) Carla M. M. Prado et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Doxorubicin-Loaded PEG-PCL-PEG Micelle Using Xenograft Model of Nude Mice: Effect of Multiple Administration of Micelle on the Suppression of Human Breast Cancer
- (2010) Nguyen-Van Cuong et al. Cancers
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
- (2009) W C Zamboni et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The emerging role of computerized tomography in assessing cancer cachexia
- (2009) Carla MM Prado et al. Current Opinion in Supportive and Palliative Care
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
- (2008) Marina Mourtzakis et al. Applied Physiology Nutrition and Metabolism
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started